((R)-4-Hydroxy-4-methyl-orn(tritc)⁷)-phalloidincyclo(-Ala-D-Thr-Cys-cis-hyp-Ala-Trp-(4R)-4-hydroxy-4-Me-orn(tritc))
CAS: 1926163-50-9
Ref. 3D-BCD16350
1mg | A consultar | |
5mg | A consultar | |
10mg | A consultar | |
25mg | A consultar | |
50mg | A consultar |
Información del producto
Fasciectomy is the surgical removal of an entire fascia. It can be used to treat a variety of conditions, including tumors and inflammation. Fasciectomy is often done in conjunction with other treatments, such as radiation therapy. This drug has been shown to decrease the growth rate of fibroblasts and induce apoptosis by targeting specific proteins. The molecular effects of this drug are dose-dependent, with higher concentrations causing more apoptosis than lower concentrations. Fasciectomy has also been shown to cause collagen loss in nodules and increased proliferation of wst-1 (a marker for cell proliferation).
Propiedades químicas
Consulta técnica sobre: 3D-BCD16350 ((R)-4-Hydroxy-4-methyl-orn(tritc)⁷)-phalloidincyclo(-Ala-D-Thr-Cys-cis-hyp-Ala-Trp-(4R)-4-hydroxy-4-Me-orn(tritc))
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.